Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) have been given an average rating of “Hold” by the seven brokerages that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is C$6.46.
A number of equities analysts have commented on the stock. CIBC boosted their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.75 and gave the stock a “neutral” rating in a report on Thursday, May 16th. National Bankshares lifted their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the stock a “sector perform” rating in a research report on Thursday, May 16th. Cormark raised shares of NorthWest Health Prop Real Est Inv Trust from a “market perform” rating to a “buy” rating in a research report on Thursday, March 21st. Finally, BMO Capital Markets lifted their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the stock a “market perform” rating in a report on Monday, May 27th.
Read Our Latest Stock Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Trading Up 0.6 %
NorthWest Health Prop Real Est Inv Trust Company Profile
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Further Reading
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- 3 Small Caps With Big Return Potential
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- High Flyers: 3 Natural Gas Stocks for March 2022
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- Canada Bond Market Holiday: How to Invest and Trade
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.